Search Results for Twitter

Showing 1 – 22

PhRMA, Lilly and AbbVie Weigh FDA Plan to Study Twitter Drug Ads By Zachary Brennan - Published 30 January 2017

When the space of characters is limited, can a link to risk information be enough for drugmakers advertising their products on social media like Twitter? That’s the question the US Food and Drug Administration (FDA) asked last November and now industry is offering their opinions on the planned studies.

Categories: News, US, FDA, Advertising and Promotion, Drugs

Tags: Twitter drug ads, pharmaceutical advertisements, FDA and pharma ads

Using Twitter as an Intelligence Tool: 85 Accounts Worth Following By Zachary Brennan - Published 16 November 2016

With the rise of president-elect Donald Trump, it’s become abundantly clear that Twitter matters. And it matters not just for politics. For regulatory affairs folks in in the pharmaceutical and medical device spaces, for investors, and even for the regulators themselves, Twitter is a great place to catch the day’s breaking news before the headlines are written.

Categories: News, Asia, Europe, US, Advertising and Promotion, Biologics and biotechnology, Business and Leadership, Communication, Drugs, Medical Devices, Regulatory intelligence, Regulatory strategy

Tags: Twitter, regulatory affairs, regulatory intelligence

Drug Marketing on Twitter: FDA to Study Space-Limited Communications By Michael Mezher - Published 07 November 2016

The US Food and Drug Administration (FDA) is planning to study whether links can be sufficient means of presenting risk information about drugs in advertising on social media platforms, such as Twitter, where character space is limited.

Categories: News, US, FDA, Advertising and Promotion, Communication, Prescription drugs

Tags: Social media, Twitter, Google

What Is 'Regulatory Intelligence?' By Patti Maguire - Published 25 May 2016

This article provides an overview of regulatory intelligence, including identifying sources, using tools for gathering information, and the importance of recognizing copyright restrictions.

Categories: Features, Regulatory intelligence, Regulatory strategy

Tags: Regulatory Intelligence, Twitter, RSS

FDA to its Scientists: Feel Free to Engage on Social Media By Zachary Brennan - Published 18 November 2015

The US Food and Drug Administration (FDA) is now encouraging employees to use social media in a personal capacity, particularly for sharing information that may benefit public health, as long as employees make clear that their opinions aren’t the views of the agency.

Categories: News, US, FDA, Biologics and biotechnology, Compliance, Drugs, Regulatory intelligence, Submission and registration

Tags: FDA, social media, FDA scientists, government social media policy, Twitter, Facebook

FDA Social Media Guidance–Lessons Learned from the Comment Period By Linda Pollitz, RAC - Published 04 November 2015

This article reviews and summarizes public comments on FDA's two draft social media guidance documents.

Categories: Features, US, FDA, Advertising and Promotion, Communication, Drugs, Regulatory strategy

Tags: Social media guidance, Character space limitations, Twitter

Social Media: Changing the Rules for Regulatory Professionals By Kelli L. Tanzella, PhD - Published 01 October 2015

This article discusses social media's role in the changing regulatory landscape and how regulatory professionals must evolve to ensure compliance with FDA requirements specific to the medical device field.

Categories: Features, US, FDA, Advertising and Promotion, Drugs, Medical Devices, Regulatory strategy

Tags: Social media, Facebook, Twitter, LinkedIn

Free the Tweets: Group Asks FDA to Allow its Scientists to Use Social Media By Alexander Gaffney, RAC - Published 19 March 2015

The US Food and Drug Administration currently lacks any policy permitting its employees to discuss scientific issues on social media channels like Twitter and Facebook, a new report by the scientific advocacy group Union of Concerned Scientists (UCS) has found.

Categories: News, US, FDA

Tags: Twitter, Social Media, FDA Social Media, Report, Union of Concerned Scientists

FDA Targets Companies for Facebook 'Likes.' Is Twitter Next? By Alexander Gaffney, RAC - Published 12 August 2014

Over the last two years, two companies have found themselves in the sights of the US Food and Drug Administration (FDA) after the regulator warned them for violating federal advertising regulations by "liking" unapproved claims on the social networking website Facebook. But while FDA's warnings have yet to set off a wider crackdown on pharmaceutical companies, recent changes to the social media platform Twitter have raised the possibility that similar attention might soon be focused there.

Categories: News, US, FDA, Compliance, Labeling

Tags: Twitter, Favorite, Favorites, Facebook, Like, Liking, Favoriting, Advertising Regulation

Using Twitter as a Regulatory Intelligence Tool: 460 Accounts Worth Following By Alexander Gaffney, RAC - Published 23 July 2014

How can regulatory professionals use Twitter as a tool to collect regulatory intelligence? This articles explains the basics of Twitter, as well as 460 accounts that life science professionals can follow to get started and make the most out of the social media platform.

Categories: News, Regulatory intelligence

Tags: Healthcare Social Media, Twitter, Social Media, Top Twitter Accounts, Top Twitter in Life Science, Top Twitter in Pharma, Top Twitter in Medical Device, Top Twitter in Biotech

FDA Warns Company for 'Liking' Status on Facebook By Alexander Gaffney, RAC - Published 09 July 2014

The US Food and Drug Administration (FDA) has issued a rare Warning Letter chiding a company for, among other reasons, improperly "liking" certain unapproved claims about its product on Facebook.

Categories: News, US, FDA, Compliance, Drugs, Labeling, Nutritional and dietary supplements

Tags: Facebook, Like, Liking, Warning Letter, Twitter

FDA Guidance: How Can Pharma and Device Companies Use Twitter? Not Easily. By Alexander Gaffney, RAC - Published 17 June 2014

The US Food and Drug Administration (FDA) today released two guidance documents focused on the use of social media by members of regulated industry, including one on how companies can use the social media platform Twitter and other space-limited platforms.

Categories: News, US, FDA, Biologics and biotechnology, Drugs, Labeling, Medical Devices

Tags: Twitter, Google, Tweets, Social Media Guidance, Guidance, Draft Guidance, Character Space Limitations

Industry Sees Much not to ‘Like’ in FDA's First Social Media Guidance Document By Alexander Gaffney, RAC - Published 16 April 2014

Categories: US, FDA

Tags: Social Media Guidance, Facebook, Twitter, Latest News, draft guidance, social media

FDA Using Twitter, Telenovelas and Translations to Reach Non-English Speakers By Alexander Gaffney, RAC - Published 15 April 2014

Categories: US, FDA

Tags: OMH, Telenovelas, YouTube, English, Twitter, Latest News, translation

Regulatory Reconnaissance (2 August 2013) By Alexander Gaffney, RF News Editor - Published 02 August 2013

Categories: News, Regulatory intelligence

Tags: Healthcare Social Media, Regulatory News, Links, Twitter, Latest News, social media, regulatory

Could FTC's New Social Media Guidance be Similar to one Pending at FDA? By Alexander Gaffney, RF News Editor - Published 13 March 2013

Categories: FDA, FTC

Tags: Social Media Guidance, Facebook, Twitter, mobile, Latest News, advertising, guidance, social media

In Midst of Crackdown, New Batch of FDA, FTC Warning Letters Target Unapproved Flu Products By Alexander Gaffney, RF News Editor - Published 15 February 2013

Categories: FDA, FTC

Tags: Crackdown, Facebook, Twitter, Flu, Latest News, warning letters

The 25 Regulatory Twitter Accounts You Need to be Following By Alexander Gaffney, RF News Editor - Published 02 January 2013

Categories: Regulatory intelligence

Tags: Regulatory News, Twitter

Clock Starts Ticking on Issuance of FDA's Social Media Guidance By Alexander Gaffney - Published 11 July 2012

Categories: FDA, Internet

Tags: Facebook, Deadline, Twitter, Latest News, marketing, guidance, social media

Watermelon and Web-links Form Basis of Drug Promotion Complaint Against Swedish Company By Alexander Gaffney - Published 25 June 2012

Tags: Webpage, Swedish Orphan Biovitrum AB, Twitter, Latest News, marketing, claims, advertising, website, information

Warning Letter Analysis: Device Companies Hit for Marketing, Social Media Problems By Alexander Gaffney - Published 13 June 2012

Tags: Greys Anatomy, TV Show, Warning Letter Analysis, Twitter, warning letter, Latest News, marketing

DHHS Looks to Social Media for Warning Signals By Alexander Gaffney - Published 22 March 2012

Tags: Twitter, Signal, Adverse Event, Latest News, DHHS, social media, disease